NCT Number: NCT01761357
Burden Comorbidities and Transcatheter Aortic Valve Implantation
The aim of the study is to determine whether the burden of comorbidities measured by CIRS-G (Cumulative Illness Rate Scale) is associated with a non-amelioration of the health related quality of life measured by questionnaire called "SF-36", six months after a transcatheter aortic valve replacement in older patients. During the comprehensive geriatric assessment realized before the valve implantation, the following data are recorded and their impact of the health related quality of life will also be analysed: comorbidity, age, depression, functional status, the cognitive impairment and malnutrition.
Looking for future studies?
Notify MeKey information
Conditions
Age range
75 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Angers Universitary Hospital, Angers, France
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patients aged 75 years and older
- Patients referred for a transcatheter aortic valve implantation
- Patients who have a comprehensive geriatric assessment realized during the three months before the valve implantation
- Patients who provide informed written consent
Exclusion criteria
- Patients who refuse the study
- Patients with a legal guardian
Treatment and study plan
Primary outcomes
-
Difference of the physical component summary score of the health survey scale called "SF36", between inclusion and one month after the valve implantation.
Time frame: 1 month
Secondary outcomes
-
Difference of the physical component summary score of the health survey scale called "SF36", between inclusion and three months after the valve implantation.
Time frame: three months
-
Difference of the physical component summary score of the health survey scale called "SF36", between inclusion and six months after the valve implantation.
Time frame: six months
-
Difference of the score of the Instrumental Activities of Daily Living scale called "IADL", between inclusion and one month after the valve implantation.
Time frame: one month
-
Difference of the score of the Instrumental Activities of Daily Living scale called "IADL", between inclusion and three months after the valve implantation.
Time frame: three months
-
Difference of the score of the Instrumental Activities of Daily Living scale called "IADL", between inclusion and six months after the valve implantation.
Time frame: six months
-
Difference of the score of the Geriatric Depression Scale (GDS), between inclusion and one month after the valve implantation.
Time frame: one month
-
Difference of the score of the Geriatric Depression Scale called "GDS", between inclusion and three months after the valve implantation
Time frame: three months
-
Difference of the score of the Geriatric Depression Scale scale called "GDS", between inclusion and six months after the valve implantation
Time frame: six months
-
Complications during the six months of follow up with all causes of mortality
Time frame: 6 months
Sponsors and collaborators
Lead sponsor
Nantes University Hospital
Other
Registry information
Official study title
Impact of Burden of Comorbidities on Health Related Quality of Life Six Months After Transcatheter Aortic Valve Implantation in Patients Aged 75 Years and Older.
Acronym: TAVIQUAL
Important dates
- Study start
- 2013
- Primary completion
- 2014
- Study completion
- 2014
- First posted
- Jan 4, 2013
- Registry last updated
- Sep 23, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
The Role of SGLT2i in Management of Moderate AS
NCT06469645
Aortic Valve Disease, Aortic Valve Stenosis
Norwich, Norfolk, United Kingdom
View Trial DetailsShort-term Exposure to High Altitude in Patients With Asymptomatic Aortic Stenosis
NCT06894550
Altitude, Altitude Sickness
Bern, Canton of Bern, Switzerland
View Trial DetailsPrognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor in Valvular Heart Disease
NCT04571372
Aortic Valve Disease, Aortic Valve Insufficiency
Seoul, South Korea
View Trial DetailsEvaluation and Validation of Management Strategy for Conductive Disorders After TAVR (EVATAVI)
NCT05417464
Aortic Valve Disease, Aortic Valve Stenosis
Montpellier, France
View Trial Details